| scholarly article | Q13442814 |
| P2093 | author name string | Sun-Mee Lee | |
| Eun-Ji Koh | |||
| Seong-Jin Yoon | |||
| P2860 | cites work | Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells. | Q53594506 |
| Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion? | Q54500904 | ||
| Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes | Q57840024 | ||
| Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases | Q73319924 | ||
| Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent | Q73939856 | ||
| Beneficial effects of losartan on vascular injury induced by advanced glycosylation end products and their receptors in spontaneous hypertension rats | Q80287063 | ||
| Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury | Q80714863 | ||
| Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-ac | Q80793721 | ||
| The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling | Q95414191 | ||
| Structural basis for telmisartan-mediated partial activation of PPAR gamma | Q27677426 | ||
| PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro | Q28146187 | ||
| Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products | Q28505279 | ||
| Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress | Q28512203 | ||
| Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model | Q28574607 | ||
| Fat and beyond: the diverse biology of PPARgamma | Q29615416 | ||
| Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury | Q31837343 | ||
| Serine/threonine protein kinases and apoptosis. | Q33876765 | ||
| Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation | Q34086987 | ||
| Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
| Guide to Receptors and Channels (GRAC), 5th edition | Q34228968 | ||
| The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses | Q34387881 | ||
| Role of mitogen- and stress-activated kinases in ischemic injury | Q34667918 | ||
| Inflammation and angiotensin II. | Q35099157 | ||
| Hepatic ischemia/reperfusion injury--a fresh look | Q35113326 | ||
| Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes | Q35612987 | ||
| Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock | Q36049326 | ||
| RAGE and modulation of ischemic injury in the diabetic myocardium | Q36756482 | ||
| Advanced glycation end products (AGEs) and their involvement in liver disease | Q37160903 | ||
| Activation of peroxisome proliferator-activated receptor-gamma during hepatic ischemia is age-dependent | Q37331860 | ||
| Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage | Q37822830 | ||
| Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
| Losartan inhibits LPS-induced inflammatory signaling through a PPARgamma-dependent mechanism in human THP-1 macrophages | Q39699893 | ||
| Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist | Q40281445 | ||
| The acute phase response is associated with retinoid X receptor repression in rodent liver | Q41728097 | ||
| Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products | Q42468287 | ||
| Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity | Q42829351 | ||
| Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats | Q45045433 | ||
| Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice | Q46846209 | ||
| Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion | Q46873543 | ||
| Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice | Q46951016 | ||
| Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation | Q47194416 | ||
| Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice | Q47214457 | ||
| The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region | Q48323135 | ||
| Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. | Q51756458 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | losartan | Q410074 |
| reperfusion injury | Q1413991 | ||
| P304 | page(s) | 1404-1416 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation | |
| P478 | volume | 169 |
| Q48051040 | AT1 receptor antagonist induces thermogenic beige adipocytes in the inguinal white adipose tissue of obese mice |
| Q26748814 | Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease |
| Q34422178 | Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice. |
| Q89701792 | Blockade of the renin-angiotensin system suppresses hydroxyl radical production in the rat striatum during carbon monoxide poisoning |
| Q34997831 | Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice |
| Q26781477 | Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma |
| Q64119944 | Effect of losartan and fish oil on plasma IL-6 and mobility in older persons. The ENRGISE Pilot randomized clinical trial |
| Q38781028 | Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease |
| Q38260264 | Investigation of phosphoproteome in RAGE signaling |
| Q38879963 | Liver regeneration - mechanisms and models to clinical application |
| Q35843026 | Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation |
| Q40402609 | Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease |
| Q28262451 | Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update |
| Q52559151 | Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver. |
| Q38795156 | Protective role of silent information regulator 1 against hepatic ischemia: effects on oxidative stress injury, inflammatory response, and MAPKs. |
| Q64062303 | Rat mRNA expression profiles associated with inhibition of ischemic acute kidney injury by losartan |
| Q51107745 | Regression of experimental endometriotic implants in a rat model with the angiotensin II receptor blocker losartan. |
| Q27010462 | Role of receptor for advanced glycation end products (RAGE) in liver disease |
| Q37561307 | Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1. |
| Q37631143 | Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation |
| Q33861931 | Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPARγ and the Akt/GSK-3β pathway |
| Q52347539 | The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment? |
Search more.